Cetrulo C L, Sbarra A J, Cetrulo C L
Department of Obstetrics and Gynecology, Tufts University School of Medicine, St. Elizabeth's Medical Center, Boston, MA 02135, USA.
J Hematother. 1996 Apr;5(2):149-51. doi: 10.1089/scd.1.1996.5.149.
Bone marrow transplantation provides successful treatment for many diseases of the immune and hematopoietic systems. The main therapeutic ingredient in this procedure is stem cells collected from the bone marrow. Recently, it has been demonstrated that stem cells from human umbilical cord blood can serve as an alternative to bone marrow transplantation in children. Although cord blood transplantation in adults has not yet been attempted, it appears that there are enough stem cells present in cord blood for successful engraftment in adults. Obstetric health care providers should be aware that many familial conditions are treatable by cord blood stem cell transplantation in children. Obstetric health care providers caring for patients with familial disorders should consider counseling such patients regarding the collection and storage of cord blood for potential future uses in autologous or allogeneic transplantation.
骨髓移植为许多免疫和造血系统疾病提供了成功的治疗方法。该 procedure 中的主要治疗成分是从骨髓中采集的干细胞。最近,已经证明来自人脐带血的干细胞可以作为儿童骨髓移植的替代方法。虽然尚未尝试成人脐带血移植,但脐带血中似乎存在足够的干细胞以成功植入成人。产科医疗保健提供者应意识到许多家族性疾病可通过儿童脐带血干细胞移植进行治疗。照顾患有家族性疾病患者的产科医疗保健提供者应考虑就采集和储存脐带血以用于未来自体或异体移植的潜在用途向此类患者提供咨询。